MD SADIKUJ JAMAN

Mr. MD SADIKUJ JAMAN

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

10 January 2025 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
MAManiruzzaman
Maniruzzaman
RBRokibul Hasan Bhuiyan
Rokibul Hasan Bhuiyan
MJMD SADIKUJ JAMAN
MD SADIKUJ JAMAN
SHShajedul Haque
Shajedul Haque

31 December 2025 in Journal of Healthcare and Biomedical Science
Verified
Journal Article
Closed access
MJMD SADIKUJ JAMAN
MD SADIKUJ JAMAN
RBRokibul Hasan Bhuiyan
Rokibul Hasan Bhuiyan
MAManiruzzaman
Maniruzzaman
MTMst Tasnova
Mst Tasnova
SMSanjida Monira
Sanjida Monira
SASaiful Islam Arif
Saiful Islam Arif
Background: Cancer remains one of the most significant global health challenges and radiotherapy continues to be one of the most effective treatment options. However, Patients are also exposed to low doses of ionizing radiation during diagnostic procedures such as computed tomography (CT) and magnetic resonance imaging (MRI). These exposures can induce various cellular and molecular defects in the human body. Therefore, there is an urgent need to develop safer and more reliable radioprotective agents to minimize radiation induced damage. Method: This review was prepared using selected keywords searched across major scientific databases including ScienceDirect, PubMed, Web of Science, MEDLINE, Embase, Scopus, Google Scholar and SCISEARCH covering publications from the inception of each data base up to October 14, 2025. Key findings: This review discusses various plants with reported radioprotective properties and compares the significance of naturally derived and pharmaceutical radioprotective agents. Conclusion: Radioprotective agents offer several advantages in both oncotherapy and diagnostic applications. However, many synthetic radioprotectors are associated with limitations such as high cost, short duration of action, toxicity and adverse effects on the central nervous system. In contrast natural radioprotectors derived from plants have shown the potential to safeguard normal cells from radiation induced radioprotectors derived from plants have shown the potential to safeguard normal cells from radiation induced damage more effectively and safely than their synthetic counterparts. The aim of this review is to identify safer and more effective radioprotective agents for use by oncologists and radiation biologists.

24 November 2025 in RADINKA JOURNAL OF HEALTH SCIENCE
Verified
Journal Article
Open access
PDF file
MJMD SADIKUJ JAMAN
MD SADIKUJ JAMAN
Molecular hydrogen is a biologically significant molecule with diverse applications in the treatment and prevention of diseases in both humans and animals. Exposure to radiation from medical procedures such as CT scans, X-rays, and radiotherapy can disrupt normal cellular functions and cause abnormal cellular behavior. These radiation-induced effects are linked to multiple signaling pathways that contribute to cellular damage. Molecular hydrogen has emerged as a promising therapeutic agent capable of mitigating radiation-related injuries and supporting the recovery of affected cellular pathways. A thorough literature search was carried out using databases including Google Scholar, PubMed, Scopus, and ScienceDirect to obtain detailed information on radiation-related cellular signaling pathways and the possible radioprotective roles of molecular hydrogen. We identified several cellular signaling pathways associated with radiation exposure. Among them are the cell cycle checkpoint pathway, DNA repair pathways, EGFR/tyrosine kinase-mediated pro-survival signaling, Rac1-mediated signaling, ERK1/2 signaling, PI3k/AKT signaling, NF-kB signaling, autophagy signaling, HIF-1α signaling, and YAP signaling pathways. Molecular hydrogen can be administered through various delivery methods and supports the recovery of many of these pathways. It also exhibits multiple beneficial effects in both humans and animals, including antioxidant, anti-apoptotic, anti-inflammatory, and gene regulatory properties. Molecular hydrogen has emerged as one of the most promising radioprotective agents, given that radiation exposure is a major contributor to carcinogenesis and cellular damage. The objective of this review is to elucidate the cellular signaling pathways influenced by radiation and to examine the potential radioprotective mechanisms of molecular hydrogen in mitigating radiation-induced biological effects.

17 September 2026 in American Journal of Chemistry and Pharmacy
Verified
Journal Article
Open access
PDF file
DSDipongkar Ray Sobuj
Dipongkar Ray Sobuj
MMMd. Maniruzzaman
Md. Maniruzzaman
TRTamanna Rashid
Tamanna Rashid
MTMst. Tasnova
Mst. Tasnova
RRRabeya Akter Rupa
Rabeya Akter Rupa
MJMD SADIKUJ JAMAN
MD SADIKUJ JAMAN
Cancer is one of the most serious and leading causes of death worldwide. Many individuals incorporate natural and nutritious foods into their diets which can help prevent cancer and reduce other health risks. Although synthetic drugs are commonly used in cancer treatment and their effectiveness is often limited by drug resistance and adverse side effects. So, physicians and researchers are increasingly focusing on natural products to enhance efficacy of conventional cancer therapies and to minimize associated toxicities. A comprehensive literature search was conducted primarily in google scholar and was supplemented by searches in PubMed, Scopus and Science Direct using relevant keywords. We found that same natural product can inhibit multiple types of cancer and may also be used in combination with pharmaceutical drugs. Important fact is that many people are unaware of anticancer activities of natural products and their potential benefits. It is equally important to highlight limitations of conventional pharmaceutical treatments. So affordable yet valuable natural products should be recognized and further investigated for their therapeutic potential in cancer prevention and treatment. This study aims to discuss different types of cancer and their relationship with natural products as well as anticancer drugs. The main objective is to investigate activity of natural products against various cancer cell types and to compare their effectiveness with that of synthetic drugs used alone. This approach may help bridge traditional and modern treatments and contributing to advancement of cancer therapy in general.

1 January 2026 in International Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
MJMD SADIKUJ JAMAN
MD SADIKUJ JAMAN
MAManiruzzaman
Maniruzzaman
RBRokibul Hasan Bhuiyan
Rokibul Hasan Bhuiyan
SHShajedul Haque
Shajedul Haque
Background: Breast cancer (BC) is the most common malignancy among women, with 2.3 million new cases and over 670,000 deaths annually. Despite advances in detection and therapy, relapse, metastasis, and resistance remain significant challenges. Tumor suppressor genes (TSGs) regulate abnormal cell division, whereas oncogenes, which arise from proto‐oncogenes, can inhibit TSGs and promote cancer progression. MicroRNAs further influence cellular processes in both normal and malignant states. Pharmaceutical agents such as tamoxifen and paclitaxel have demonstrated efficacy, while natural products, including baicalin and ursolic acid, show promise in modulating oncogenic pathways. Understanding BC subtypes is crucial, as they guide prognosis and enable more precise and personalized treatment strategies. These insights emphasize the complex molecular landscape and evolving approaches to BC therapy. Objective: The review was conducted using a defined set of keywords to search PubMed, Web of Science, Embase, Scopus, Google Scholar, and SciSearch databases covering publications from the inception of each database through August 2, 2025. Key Findings: This review outlines BC subtypes and their molecular features, highlighting TSGs, oncogenes, and miRNAs as therapeutic targets. Both synthetic drugs and natural compounds demonstrate potential applications in advancing BC treatment strategies. Conclusion: BC subtypes, defined by morphology and molecular features, remain vital for targeted therapy advancement. TSGs, oncogenes, and miRNAs play key roles in subtype regulation and require further study for precise detection and treatment. Synthetic drugs and natural compounds show promise as therapeutic agents. However, continued molecular research is essential to improve personalized strategies and overcome relapse, metastasis, and resistance in BC management.